The significance of lipoproteins in serum binding variations of propofol

Anesthesia and Analgesia

Volumn 87, Issue 5, 1998, Pages 1147-1151

  Zamacona, M K ^a   Suarez E ^a   Garcia E ^b   Aguirre, C ^a   Calvo, R ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROPOFOL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; DRUG UPTAKE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

ADULT; ANESTHETICS, INTRAVENOUS; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PROPOFOL; PROTEIN BINDING; SPECTROMETRY, FLUORESCENCE; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 0345698742     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199811000-00032     Document Type: Article

References (24)

1. Stokes DN, Hutton P. Rate-dependent induction phenomena with propofol: implications for the relative potency of intravenous anesthetics. Anesth Analg 1991;72:578-83.
2. Smith I, White PF, Nathanson M, Gouldson R. Propofol. An update on its clinical use. Anesthesiology 1994;81:1005-43.
3. Vuyk J, Engbers FH, Lemmens HJ, et al. Pharmacodynamics of propofol in female patients. Anesthesiology 1992;77:3-9.
4. Lemmens HJ, Burn AG, Bovill JG. Pharmacodynamics of alfentanil: the role of plasma protein binding. Anesthesiology 1992;76:65-70.
5. Gin T. Pharmacodynamics of propofol and free drug concentrations. Anesthesiology 1993;78:604-5.
6. McClean GJ, Fogarty DF, Watters CH. Factors that influence the induction dose of propofol. Anaesthesia 1991;46:59-61.
7. Garrido MJ, Jiménez RM, Rodríguez-Sasiaín JM, et al. Characterization of the protein binding of propofol and its possible interactions. Rev Esp Anest Reanim 1994;41:308-12.
8. Costela J L, Jiménez R, Calvo R, Suárez E, Carlos R. Serum protein binding in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand 1996;40:741-5.
9. Zamacona MK, Suárez E, Aguilera L, et al. Serum protein binding of propofol in critically ill patients. Acta Anaesthesiol Scand 1997;41:1267-72.
10. Wassan KM. Modifications in plasma lipoproteins concentration and lipid composition regulate the biological activity of hydrophobic drugs. J Pharmacol Toxicol 1996;36:1-13.
11. Wassan KM, Morton RE. Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin. Pharm Res 1996;13:462-8.
12. Gardier AM, Mathé D, Guédeney X. Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther Drug Monit 1993;15:274-80.
13. Lemaire M, Tillement JP. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J Pharm Pharmacol 1982;34:715-8.
14. Zini R. Methods in drug protein biding analysis. In: Kuemmerle H, Shibuya T, Tillement JP, eds. Human pharmacology. Amsterdam: Elsevier, 1991:235-82.
15. Chan K, So APC. The measurement of propofol in human blood samples by liquid chromatography. Methods Find Exp Clin 1990;12:135-9.
16. Chassany O, Urien S, Claudepierre P, et al. Binding of anthracycline derivatives to human serum lipoproteins. Anticancer Res 1994;12:2353-6.
17. Cockshott ID, Douglas EJ, Plummer GF, et al. The pharmacokinetics of propofol in laboratory animals. Xenobiotica 1992;50: 636-57.
18. Lemaire M, Urien S, Albengres E, et al. Lipoprotein binding of drugs. In: Reidenberg MM, Erill S, eds. Drug-protein binding. New York: Praeger, 1986:93-108.
19. Ghoneim MM, Pandya H. Plasma protein binding of thiopental in patients with impaired renal or hepatic function. Anesthesiology 1975;42:545-9.
20. Hervé F, Urien S, Albengres E, et al. Drug binding in plasma: a summary of recent trends in the study of drug and hormone binding. Clin Pharmacokinet 1994;26:44-58.
21. Gupta SK, Benet LZ. High-fat meals increase the clearance of cyclosporine. Pharm Res 1990;7:46-8.
22. Kishor M, Vadiei K, Lopez-Berestein G, et al. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J Infect Dis 1990;161:562-6.
23. Warmington A. Extreme resistance to general anaesthetics [letter]. Anaesth Intensive Care 1994;22:627.
24. Fulton B, Sorkin EM. Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995;50:636-57.